Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| ThyPRO : Échelle des résultats rapportés par les patients liés à la thyroïde× | AddiQoL : Échelle de qualité de vie pour l'insuffisance surrénale× | |
|---|---|---|
| Domaine | Endocrinologie | Endocrinologie |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 2009 | 2012 |
| Auteur d'origine≠ | Torquil Watt, Jens Bjørner, Marianne Groenvold | Adriana Evers, Jeanieke Tiemensma |
| Type | Patient self-report questionnaire | Patient self-report questionnaire |
| Source fondatrice≠ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ | Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508. link ↗ |
| Alias | ThyPRO-85, ThyPRO-39 | Addison Quality of Life, AI-QoL |
| Apparentées | 3 | 3 |
| Résumé≠ | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. | AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations. |
| ScholarGateJeu de données ↗ |
|
|